Current status of carboplatin desensitization therapy for gynecologic malignancies
Journal of Gynecologic Oncology · 2026
DOI: 10.3802/jgo.2026.37.e11 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Gynecologic Oncology, 2026. Verfasst von Hiroshi Nishio und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan. nishio.z3@keio.jp. Hauptthemen laut MEDLINE: Carboplatin, Genital Neoplasms, Female, Desensitization, Immunologic, Drug Hypersensitivity. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Platinum-based chemotherapies are widely used in the treatment of gynecologic malignancies and are standard treatment for initial treatment and recurrent diseases. Due to the widespread use of platinum-based regimens, the management of platinum hypersensitivity reactions (HSRs) is an important issue for physicians treating gynecologic malignancies. Patients receiving multiple lines of platinum therapy, with long intervals between platinum lines and history of allergic reaction, and status of germline BRCA mutation are at an increased risk of platinum HSRs. The development of desensitization protocols to allow patients with platinum hypersensitivity to receive further therapy is mandatory. Each institution should work with its' multidisciplinary team to select a protocol that best suits individual practice setting and patient population to maximize patients care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan. nishio.z3@keio.jp.
- Department of Medical Oncology, Hyogo Cancer Center, Akashi, Japan.
- Department of Obstetrics and Gynecology, Tottori University School of Medicine, Yonago, Japan.
- Department of Obstetrics and Gynecology, Iwate Medical University School of Medicine, Morioka, Japan.
- Department of Obstetrics and Gynecology, The Jikei University School of Medicine, Tokyo, Japan.
- Department of Obstetrics and Gynecology, Kurume University School of Medicine, Kurume, Japan.
ORCID-Profile: Hiroshi Nishio, Koji Matsumoto, Hiroaki Komatsu, Mitsunori Morita, Takayuki Nagasawa, Jiro Suzuki, Shin Nishio, Mitsuya Ishikawa, Toyomi Satoh
Zitieren
APA
Nishio, H., Matsumoto, K., Komatsu, H., Morita, M., Nagasawa, T., Suzuki, J., Nishio, S., Ishikawa, M., & Satoh, T. (2026). Current status of carboplatin desensitization therapy for gynecologic malignancies. Journal of Gynecologic Oncology. https://doi.org/10.3802/jgo.2026.37.e11
Vancouver
Nishio H, Matsumoto K, Komatsu H, Morita M, Nagasawa T, Suzuki J, et al. Current status of carboplatin desensitization therapy for gynecologic malignancies. Journal of Gynecologic Oncology. 2026. doi:10.3802/jgo.2026.37.e11
BibTeX
@article{Nishio2026,
author = {Nishio, Hiroshi and Matsumoto, Koji and Komatsu, Hiroaki and Morita, Mitsunori and Nagasawa, Takayuki and Suzuki, Jiro and Nishio, Shin and Ishikawa, Mitsuya and Satoh, Toyomi},
title = {Current status of carboplatin desensitization therapy for gynecologic malignancies},
journal = {Journal of Gynecologic Oncology},
year = {2026},
doi = {10.3802/jgo.2026.37.e11}
}
EUVIMED